These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5798943)

  • 1. The issue of "generic" versus "trade" names.
    Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):1-2. PubMed ID: 5798943
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 3. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract]   [Full Text] [Related]  

  • 4. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 5. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescriptions imported into the United States.
    Tenn Med; 2004 Aug; 97(8):337. PubMed ID: 15376708
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 8. "Off-label" psychotropic medication use in children.
    Regan J; Alderson A
    Tenn Med; 2003 Sep; 96(9):429-31. PubMed ID: 14513532
    [No Abstract]   [Full Text] [Related]  

  • 9. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 10. Will PPIs affect your patients' attitudes?
    Patient Care; 1979 Feb; 13(3):190-1, 195-6. PubMed ID: 10240261
    [No Abstract]   [Full Text] [Related]  

  • 11. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 12. Importing prescription drugs: risky business.
    Hassel L; Arzuaga P
    Empl Benefits J; 2003 Dec; 28(4):83-6. PubMed ID: 14712740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 14. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More states adopt generic substitution laws.
    Goldsmith LS
    J Leg Med (N Y); 1977 Oct; 5(10):31-2. PubMed ID: 303272
    [No Abstract]   [Full Text] [Related]  

  • 16. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 17. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 20. The regulatory role of the United States Food and Drug Administration.
    Ortiz EM
    J Reprod Med; 1972 Apr; 8(4):205-6. PubMed ID: 5029971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.